WINNING THE BATTLE AGAINST ENDOTOXIC SEPTIC SHOCK

The first theranostic: EAA™ & Toraymyxin

Spectral welcomes Emory University as its 20th site for the Tigris clinical trial.

k

PRESS RELEASE

Spectral Medical Provides Tigris Trial Update

TORONTO, Canada – April 10, 2024 - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris trial, a...

read more
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update

March 28, 2023

Spectral Medical Provides February Tigris Trial Update

93 patients enrolled February represents a second record breaking consecutive month for patient enrollment TORONTO, Canada – February 28, 2024 - Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) a late-stage theranostic company advancing...

read more

INVESTOR UPDATE

February 2024 Investor Update Presentation

Spectral Tigris Trial and Corporate Update Replay

February 2024

crrt conference 2024

CRRT Conference Breakfast Symposium
Waking up to Endotoxemic Septic Shock. What do you need to be ready?
Wednesday March 13, 2024
San Diego, CA

Moderators: John Kellum and Debra Foster
Diagnosing ESS in the real world – Danielle Davison, George Washington University
Treating ESS in the real world – Javier Neyra, University of Alabama
Implementing PMX hemoadsorption at the bedside – Johann Chang, (Spectral), Tara Morgan-Gray, (Colorado Springs)

the balancing act on lifetime tv

Endotoxic Septic Shock  as featured on The Balancing Act on Lifetime TV.